Gabriele Catena

Adipose tissue dysfunction and metabolic disorders: Is it possible to predict who will develop type 2 diabetes mellitus? Role of markErs in the progreSsion of dIabeteS in obese paTIeNts (The RESISTIN trial)

Giuseppe Derosa, Gabriele Catena, Giovanni Gaudio et al. · Cytokine · 2019 · 39 citations

Insulin Resistance, Metabolic Syndrome, Obesity +11

Effects on oral fat load of a nutraceutical combination of fermented red rice, sterol esters and stanols, curcumin, and olive polyphenols: A randomized, placebo controlled trial

Giuseppe Derosa, Gabriele Catena, Riccardo Raddino et al. · Phytomedicine · 2018 · 34 citations

Obesity, Nutrition, Medicine +6

LDL-cholesterol control in the primary prevention of cardiovascular diseases: An expert opinion for clinicians and health professionals

Andrea Poli, Alberico L. Catapano, Alberto Corsini et al. · Nutrition Metabolism and Cardiovascular Diseases · 2022 · 24 citations · Full text

Effects of Sitagliptin on Lipid Profile in Patients With Type 2 Diabetes Mellitus After 7 Years of Therapy

Giuseppe Derosa, Isabella Tritto, Davide Romano et al. · The Journal of Clinical Pharmacology · 2019 · 12 citations

Glyco‐metabolic control, inflammation markers, and cardiovascular outcomes in type 1 and type 2 diabetic patients on insulin pump or multiple daily injection (italico study)

Giuseppe Derosa, Gabriele Catena, Laura Scelsi et al. · Diabetes/Metabolism Research and Reviews · 2019 · 11 citations